Day: February 12, 2021

BEVERLY, Mass., Feb. 12, 2021 (GLOBE NEWSWIRE) — LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, announces that Mr. Daryl Rebeck will resign from the Board and his position as the President of the Company effective February 15, 2021, and Stephen J. Mastrocola has joined LexaGene’s Board of Directors.Dr. Jack Regan, LexaGene’s CEO and Founder, states, “I’m immensely grateful to Daryl for being my partner and helping me found this company four years ago. I would like to thank him for all his hard work and leadership and wish him great success in his future endeavors.”Mr. Daryl Rebeck comments, “The pandemic has certainly presented some challenges for me to travel to the Beverly office while based outside of the country....

Company’s Revised Website Goes Live at 5:00 pm ESTST. PETERSBURG, FL, Feb. 12, 2021 (GLOBE NEWSWIRE) — Global Technologies, Ltd (OTC Pink: GTLL), a holding corporation, which through its subsidiaries, has operations engaged in the online sales of CBD and hemp related products, the acquisition of intellectual property in the safety and security space and as a portal for entrepreneurs to provide immediate access to live shopping, e-commerce, product placement in brick and mortar retail outlets and logistics is pleased to inform shareholders that the Company has filed a Complaint against certain shareholders to return over 3.4 Billion shares of the Company’s common stock to treasury.On February 9, 2021, Global Technologies, Ltd filed a Complaint for Declaratory Judgment in the Circuit Court of the Eleventh Judicial Circuit in and for...

TORONTO, Feb. 12, 2021 (GLOBE NEWSWIRE) — BlackRock Asset Management Canada Limited (“BlackRock Canada”), an indirect, wholly-owned subsidiary of BlackRock, Inc. (NYSE: BLK), today announced the February 2021 cash distributions for the iShares ETFs listed on the TSX or NEO which pay on a monthly basis as well as XIU. Unitholders of record of a fund on February 23, 2021 will receive cash distributions payable in respect of that fund on February 26, 2021.Details regarding the “per unit” distribution amounts are as follows:(1) Distribution per unit amounts are in U.S. dollars for XDG.U, XDU.UFurther information on the iShares Funds can be found at http://www.blackrock.com/ca.About BlackRockBlackRock’s purpose is to help more and more people experience financial well-being. As a fiduciary to investors and a leading provider of financial...

PLANO, Texas, Feb. 12, 2021 (GLOBE NEWSWIRE) — INTRUSION Inc. (NASDAQ: INTZ), a leading provider of entity identification, high speed data mining, cybercrime and advanced persistent threat detection services, will release its fourth quarter and fiscal 2020 financial results on February 25, 2021 after market close. Jack Blount, President and CEO, and Franklin Byrd, CFO, will host a conference call at 4:00 p.m. Central Time to discuss the Company’s financial results.The conference call will be broadcast live in listen-only mode on the investor relations website at www.intrusion.com.Analysts and investors who would like to join the live call via teleconference are invited to dial in using the following information:Date: Thursday, February 25, 2021Time: 4:00 p.m. Central TimeConference Call Number: 1-833-366-0416International Call Number:...

San Juan, Puerto Rico, Feb. 12, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — BOTS, Inc. (OTC MARKETS: BTZI), an emerging innovator of products, technologies, and services for the rapidly growing cyber-security, digital robotics automation and A.I. for the manufacturing industry, announced today its initiative on building a global supply chain platform based on advanced blockchain technology with a focus on the legal cannabis industry.  Cannabis companies will benefit from blockchain technology for a range of applications, from optimizing efficiency to transparency in business transactions, to securely storing and monitoring inventory, financial and regulatory data on the blockchain involving a concept known as “Seed-to-Sale.”Technology executives in the Cannabis Industry are considering the following key benefits in...

CALGARY, Alberta, Feb. 12, 2021 (GLOBE NEWSWIRE) — Canacol Energy Ltd. (“Canacol” or the “Corporation”) (TSX:CNE; OTCQX:CNNEF; BVC:CNEC) is pleased to announce that Mr. Juan Argento has been appointed to the Board of Directors.Mr. Argento brings deep experience in energy, finance and capital markets to the Board of Directors of Canacol. He is currently one of two Managing Partners at Horizon Capital (“Horizon”). Horizon was founded in 2004 as an advisory and principal investment firm focused on the Latin American energy industry. Prior to joining Horizon, Mr. Argento was an advisor to Millennium Global (“Millennium”), a London-based hedge fund group. Mr. Argento advised Millennium with regards to investments in public and private markets. He was particularly active in oil & gas, mining and agriculture....

TORONTO, Feb. 12, 2021 (GLOBE NEWSWIRE) — RioCan Real Estate Investment Trust (“RioCan”) (TSX: REI.UN) today announced a distribution of 8 cents per unit for the month of February. The distribution will be payable on March 5, 2021 to unitholders of record as at February 26, 2021.About RioCanRioCan is one of Canada’s largest real estate investment trusts. RioCan owns, manages and develops retail-focused, increasingly mixed-use properties located in prime, high-density transit-oriented areas where Canadians want to shop, live and work. As at December 31, 2020, our portfolio is comprised of 223 properties with an aggregate net leasable area of approximately 38.3 million square feet (at RioCan’s interest) including office, residential rental and 14 development properties.   To learn more about us, please visit www.riocan.com.Information...

NEW HAVEN, Conn., Feb. 12, 2021 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (“BioXcel” or the “Company”) (Nasdaq: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced that the Company will host a virtual Key Opinion Leader (“KOL”) event on Friday, February 19, 2021 from 11:00 am ET to 2:00 pm ET. The event aims to highlight BXCL501, the Company’s investigational, proprietary, orally dissolving thin film formulation of dexmedetomidine (“Dex”), and its potential as a treatment option for multiple neuropsychiatric conditions.BioXcel’s management team will be joined by leading experts for each indication to discuss the significant unmet medical need and BXCL501’s potential to change the treatment paradigm.KOL...